Frontiers in Immunology

Original Research

Accepted on 24 Jan 2025

Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination

in Cancer Immunity and Immunotherapy

Katja Ursic Valentinuzzi
Urska Kamensek
Simona Kranjc Brezar
Chloe Heranney
Tilen Komel
Simon Bucek
Maja Cemazar
Gregor Sersa

Frontiers in Immunology

doi 10.3389/fimmu.2025.1470432

Original Research

Accepted on 24 Jan 2025

Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancers progression and immune infiltration

in Cancer Immunity and Immunotherapy

Xinyue Shi
Jingyu Zang
Qi Gu
Mengmeng Zhang
Handi Sun
Li Jun Y ang
Jiahui Cheng
Ruonan Wang
Han Mao
Aitong Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1480771

Mini Review

Accepted on 24 Jan 2025

Progress on Diagnosis and Treatment of Multisystem Inflammatory Syndrome in Children

in Inflammation

Zhe Peng
Gang Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551122

Original Research

Accepted on 24 Jan 2025

Elevated levels of IRF1 and CASP1 as pyroptosis-related biomarkers for intestinal epithelial cells in Crohn's disease

in Cytokines and Soluble Mediators in Immunity

Xiaofang Xu
Xiaodan Lv
Ruizhi Zeng
Zhixi Huang
Ziqian 1102078101@qq.com
Bing Han
Guangfu Lin
Jianing Lin
Shiquan Lin
Junhua Fan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551547

Review

Accepted on 24 Jan 2025

Targeting Amino Acid Metabolism to Inhibit Gastric Cancer Progression and Promote Anti-tumor Immunity: A Review

in Cancer Immunity and Immunotherapy

Yuchun Jiang
Qing Tao
Xuehan Qiao
Yang Yufei
Chen Peng
Miao Han
Kebin Dong
Wei Zhang
Min Xu
Deqiang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1508730

Original Research

Accepted on 24 Jan 2025

Prognostic Value of Body Adipose Tissue Parameters in Cancer Patients Treated with Immune Checkpoint Inhibitors

in Cancer Immunity and Immunotherapy

Li Yan
yean yu
Kun Lv
Xie Xie
Rongjuan Ge

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557726

Correction

Accepted on 24 Jan 2025

Corrigendum: Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Scores and Clinical Outcomes after Haploidentical Stem Cell Transplantation in Pediatric Patients with Relapsed Neuroblastoma

in Alloimmunity and Transplantation

Eunseop Seo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565304

Review

Accepted on 24 Jan 2025

Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics

in Microbial Immunology

Lei Zhang
Xichu Duan
Yanhua Zhao
Dejiu Zhang
Yuan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526589

Original Research

Accepted on 24 Jan 2025

A Modified mRNA Vaccine prevents Enterovirus A71 Infection in mouse model

in Vaccines and Molecular Therapeutics

Yuming Li
Fengyu Chi
Xu Zhang
Dong Zhang
Airu Zhu
Zhen Zhuang
Zhaoyong Zhang
Zhenjie Zhang
Chuansong Quan
Kaixiao Nie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535758

Original Research

Accepted on 24 Jan 2025

Superior Precision in Lupus Diagnosis: T Cell Autoantibodies and TC4d Outperform Conventional Systemic Lupus Erythematosus Biomarkers

in T Cell Biology

Vasileios Kyttaris
Daniel J Wallace
Arezou Khosroshahi
Andrew Concoff
Nicole Wilson
Chau-ching Liu
Susan Manzi
Joseph Ahearn
Sepehr Taghavi
Touba Warsi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518208

Original Research

Accepted on 24 Jan 2025

Advanced disease and CD8 + TEMRA cells predict severe infections in Multiple Myeloma

in Cancer Immunity and Immunotherapy

Eva Tranter
David Busch
Clarissa Heck
Igor Wolfgang Blau
Axel Nogai
Phillip Schiele
Christian Meisel
Lars Bullinger
Marco Frentsch
Il-Kang Na

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532645

Correction

Accepted on 24 Jan 2025

Immune Monitoring of Trabectedin Therapy in Refractory Soft Tissue Sarcoma Patients -the IMMUNYON Study

in Cancer Immunity and Immunotherapy

Paulo Rodrigues-Santos

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562345

Original Research

Published on 24 Jan 2025

Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance

in Molecular Innate Immunity

Santiago Rodríguez de Córdoba
Andrea Reparaz
Daniel Sanchez
Sheila Pinto
Lucia Juana Lopez
Héctor Martin Merinero
Iria Calvete
Julian Perez-Perez
Sydney S. Jellison
Yuzhou Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527016

263 views

Correction

Published on 24 Jan 2025

Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19

in Viral Immunology

Mingquan Guo
Menglu Gao
Jing Gao
Tengfei Zhang
Xin Jin
Jian Fan
Qianying Wang
Xin Li
Jian Chen
Zhaoqin Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1548101

178 views

Review

Published on 24 Jan 2025

The success of the tumor immunotherapy: neutrophils from bench to beside

in Cancer Immunity and Immunotherapy

Meng Zhu
Ru Jia
Xiaojie Zhang
Pingwei Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524038

271 views

Review

Published on 24 Jan 2025

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects

in Cancer Immunity and Immunotherapy

Zhi-Xun Guo
Jia-Li Ma
Jin-Qiu Zhang
Ling-Ling Yan
Ying Zhou
Xin-li Mao
Shao-Wei Li
Xian-Bin Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524801

125 views

Navigation group

Articles

Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination

Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancers progression and immune infiltration

Progress on Diagnosis and Treatment of Multisystem Inflammatory Syndrome in Children

Elevated levels of IRF1 and CASP1 as pyroptosis-related biomarkers for intestinal epithelial cells in Crohn's disease

Targeting Amino Acid Metabolism to Inhibit Gastric Cancer Progression and Promote Anti-tumor Immunity: A Review

Prognostic Value of Body Adipose Tissue Parameters in Cancer Patients Treated with Immune Checkpoint Inhibitors

Corrigendum: Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Scores and Clinical Outcomes after Haploidentical Stem Cell Transplantation in Pediatric Patients with Relapsed Neuroblastoma

Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics

A Modified mRNA Vaccine prevents Enterovirus A71 Infection in mouse model

Superior Precision in Lupus Diagnosis: T Cell Autoantibodies and TC4d Outperform Conventional Systemic Lupus Erythematosus Biomarkers

Advanced disease and CD8 + TEMRA cells predict severe infections in Multiple Myeloma

Immune Monitoring of Trabectedin Therapy in Refractory Soft Tissue Sarcoma Patients -the IMMUNYON Study

Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance

Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19

The success of the tumor immunotherapy: neutrophils from bench to beside

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects